Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts.
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts. Alzheimers Dement. 2025 Feb; 21(2):e14489.
PMID: 39968692Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials.
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials. J Prev Alzheimers Dis. 2025 Feb 15; 100075.
PMID: 39956674Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach.
Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach. Alzheimers Res Ther. 2025 Feb 06; 17(1):38.
PMID: 39915859Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy.
Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy. Alzheimers Dement. 2025 Jan; 21(1):e14202.
PMID: 39807681Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS.
Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS. Alzheimers Dement. 2025 Feb; 21(2):e14439.
PMID: 39713873Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.
Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI. Alzheimers Dement. 2025 Jan; 21(1):e14218.
PMID: 39711228Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia.
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia. Alzheimers Dement. 2025 Feb; 21(2):e14448.
PMID: 39713899Atypical Presentations of Alzheimer Disease.
Atypical Presentations of Alzheimer Disease. Continuum (Minneap Minn). 2024 Dec 01; 30(6):1614-1641.
PMID: 39620837Clinical Manifestations.
Clinical Manifestations. Alzheimers Dement. 2024 Dec; 20 Suppl 3:e090906.
PMID: 39750399Assessment of disease impact through health-related quality of life measurement in primary progressive aphasia.
View All Publications
Assessment of disease impact through health-related quality of life measurement in primary progressive aphasia. Alzheimers Dement (N Y). 2024 Oct-Dec; 10(4):e12499.
PMID: 39748847
People
Emily Rogalski, PhD
-
Rosalind Franklin PhD Professor of Neurology
Professor of Neuroscience Institute - Research and Scholarly Interests: Aging Well, Aging, Healthy, Alzheimer Dementia, Alzheimer Disease, Behavoiral intervention, Caregiver, Cognitive Functions, Communication, Partner, Community Health, Frontotemporal Dementia, Magnetic Resonance Imaging, Neurology, Neuropsychology, Neuroscience, Positron Emission Tomography, Primary Progressive Aphasia, Randomized Controlled Trial, Social Work, Speech Language Pathology, SuperAging
- Websites: Healthy Aging & Alzheimer's Research Care Center, Research Network Profile
- Contact: erogalski@uchicago.edu
- Graduate Program: PhD Program in Neurobiology